Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides

Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma

(2013) Marianeve Polimeno et al.   BJU INTERNATIONAL

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma

(2012) Hang Li et al.   HEPATOLOGY

Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation

(2012) Ching-Yih Lin et al.   JOURNAL OF CLINICAL PATHOLOGY

VCP/p97, Down-Regulated by microRNA-129-5p, Could Regulate the Progression of Hepatocellular Carcinoma

(2012) Yu Liu et al.   PLoS One

Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901

(2012) Steffen Walter et al.   OncoImmunology

HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells

(2011) Toshiaki Yoshikawa et al.   CANCER SCIENCE

Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

(2011) Shinichiro Motohashi et al.   CLINICAL IMMUNOLOGY

Successful Outcomes Using Combination Therapy of Interleukin-2 and Interferon-  for Renal Cell Carcinoma Patients with Lung Metastasis

(2010) H. Akaza et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The THAP-Zinc Finger Protein THAP1 Associates with Coactivator HCF-1 andO-GlcNAc Transferase

(2010) Raoul Mazars et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

(2010) Osama E Rahma et al.   Journal of Translational Medicine

A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer

(2010) Masanori Noguchi et al.   PROSTATE

Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response

(2010) Sharvan Sehrawat et al.   PLoS Pathogens

Functional Analysis of 11q13.5 Amplicon Identifies Rsf-1 (HBXAP) as a Gene Involved in Paclitaxel Resistance in Ovarian Cancer

(2009) Jung Hye Choi et al.   CANCER RESEARCH

Vaccine Therapy in Patients with Renal Cell Carcinoma

(2009) Hein Van Poppel et al.   EUROPEAN UROLOGY

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients

(2009) Sei Naito et al.   EUROPEAN UROLOGY

TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts

(2009) Galya Abrham et al.   INTERNATIONAL JOURNAL OF CANCER

Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase

(2009) Yanwu Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies

(2009) Yael Michaeli et al.   JOURNAL OF IMMUNOLOGY

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

(2009) Masashi Kajiro et al.   NATURE CELL BIOLOGY

Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005)

(2008) Arie S. Belldegrun et al.   CANCER

Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma

(2008) E. Sato et al.   CLINICAL CANCER RESEARCH

Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma

(2008) L. Pavone et al.   MEDICAL ONCOLOGY

Natural killer cell–directed therapies: moving from unexpected results to successful strategies

(2008) Magali Terme et al.   NATURE IMMUNOLOGY